AcelRx Pharmaceuticals, Inc. - stock earnings
Stock symbol ACRX is outdated, potentially delisted? Maybe it is available on other exchange?
ACRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -4.4 million USD | 253000 USD |
| 2022Q3 | -6.8 million USD | 507000 USD |
| 2022Q2 | 70.7 million USD | 570000 USD |
| 2022Q1 | -8.7 million USD | 442000 USD |
| 2021Q4 | -7.9 million USD | 2000 USD |
| 2021Q3 | -8.4 million USD | 1.9 million USD |
| 2021Q2 | -9.9 million USD | 443000 USD |
| 2021Q1 | -9.0 million USD | 511000 USD |
| 2020Q4 | -8.9 million USD | 738000 USD |
| 2020Q3 | -8.9 million USD | 1.4 million USD |
| 2020Q2 | -6.6 million USD | 2.9 million USD |
ACRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -35.1 million USD | 2.8 million USD |
| 2020 | -40.4 million USD | 5.4 million USD |
| 2019 | -53.2 million USD | 2.3 million USD |
| 2018 | -47.1 million USD | 2.2 million USD |
| 2017 | -51.5 million USD | 8.0 million USD |
ACRX
Price: $0.86
52 week price:
Dividend Yield: 1.18%
Payout Ratio Range:
Earnings Per Share: -2.75 USD
P/E Ratio: -0.28
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 171100
Ebitda: -8.4 millionMarket Capitalization: 13.1 million